Ying‐Jun Chang - Concepedia

Author

Ying‐Jun Chang

Peking University ORCID

Also Known As

Huan Chen, Xiang‐Yu Zhao, Xiao‐Su Zhao, Y Chang, Y J Chang, Y. Chang, Y. chang, Y.-J. Chang, Y.J. Chang, Y.‐J. Chang

483

Publications

7.2K

Citations

H-Index

112

Concepts

All Affiliations

Peking University Peking University People's Hospital Center for Life Sciences Chinese Academy of Medical Sciences & Peking Union Medical College National Clinical Research Center for Digestive Diseases

About

Ying‐Jun Chang is an author at Peking University specializing in medicine, immunology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	64	1.9K
2	Health Sciences	16	24	663
3	Allergy	3	3	116
4	Public Health	2	2	31
5	Engineering	1	1	23

Ying‐Jun Chang

151

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Who is the best donor for a related HLA haplotype-mismatched transplant? Yu Wang, Ying‐Jun Chang, Lan‐Ping Xu, Blood	2014	350
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets Ying‐Jun Chang, Lan‐Ping Xu, Xiaohui Zhang, Journal of Hematology & Oncology	2015	199
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis Ying‐Jun Chang, Yu Wang, Yanrong Liu, Journal of Hematology & Oncology	2017	173
Association of an Impaired Bone Marrow Microenvironment with Secondary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation Yuan Kong, Ying‐Jun Chang, Yazhe Wang, Biology of Blood and Marrow Transplantation ImmunologyPathologyCell Replacement TherapySecondary PgfBone Marrow Failure	2013	130
The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission Xiao‐Jun Huang, Hong‐Hu Zhu, Ying‐Jun Chang, Blood	2012	122
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study Ying‐Jun Chang, Depei Wu, Yongrong Lai, Journal of Clinical Oncology	2020	120
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation Ying‐Jun Chang, Lan‐Ping Xu, Yu Wang, Journal of Clinical Oncology	2016	111
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus Xuying Pei, Xiang‐Yu Zhao, Ying‐Jun Chang, The Journal of Infectious Diseases	2017	102
Aging-induced IL27Ra signaling impairs hematopoietic stem cells Hanqing He, Panglian Xu, Xiaofei Zhang, Blood	2020	93
Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality Jun Liu, Jun Kong, Ying‐Jun Chang, Clinical Microbiology and Infection Cell TherapyTransplantationCmv DiseaseHematologyImmunology	2015	92

Page 1